v3.25.2
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Manufacturing Commitments and Contingencies

The following table summarizes manufacturing commitments and contingencies as of the period indicated (in thousands):

 

 

 

June 30, 2025

 

GEMA:

 

 

 

Achievement of certain milestones related to validation of API supplied by GEMA and
    regulatory approval of MOLBREEVI drug substance produced at GEMA

 

$

230

 

PARI:

 

 

 

Achievement of various development activities and regulatory approval of proprietary
     nebulizer utilized to administer MOLBREEVI

 

 

586

 

Total manufacturing and other commitments and contingencies

 

$

816